BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25419829)

  • 21. Influence of different oxygenator types on changing frequency, infection incidence, and mortality in ARDS patients on veno-venous ECMO.
    Robak O; Lakatos PK; Bojic A; Hermann A; Laczika KF; Chiari A; Hiesmayr JM; Staudinger T; Locker GJ
    Int J Artif Organs; 2014 Nov; 37(11):839-46. PubMed ID: 25362902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxygenator impact on peramivir in extra-corporeal membrane oxygenation circuits.
    Cies JJ; Moore WS; Marino D; Deacon J; Enache A; Chopra A
    Perfusion; 2023 Apr; 38(3):501-506. PubMed ID: 35225084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a preprimed microporous hollow-fiber membrane for rapid response neonatal extracorporeal membrane oxygenation.
    Walczak R; Lawson DS; Kaemmer D; McRobb C; McDermott P; Smigla G; Shearer I; Lodge A; Jaggers J
    Perfusion; 2005 Sep; 20(5):269-75. PubMed ID: 16231623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a new silicone membrane oxygenator for ECMO.
    Nakata K; Maeda T; Murabayashi S; Yoshikawa M; Takano T; Iwasaki A; Nonaka K; Linneweber J; Kawahito S; Glueck J; Sato K; Kuwana J; Nosé Y
    Ann Thorac Cardiovasc Surg; 2000 Dec; 6(6):373-7. PubMed ID: 11173351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A potential propensity for failure secondary to clot embolism in neonatal ECMO.
    Khoshbin E; Machin D; Killer H; Peek GJ; Sosnowski AW; Firmin RK
    Perfusion; 2005 May; 20(3):177-81. PubMed ID: 16038390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro drug adsorption and plasma free hemoglobin levels associated with hollow fiber oxygenators in the extracorporeal life support (ECLS) circuit.
    Preston TJ; Hodge AB; Riley JB; Leib-Sargel C; Nicol KK
    J Extra Corpor Technol; 2007 Dec; 39(4):234-7. PubMed ID: 18293808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracorporeal membrane oxygenation and V/Q ratios: an ex vivo analysis of CO
    Zakhary B; Sheldrake J; Pellegrino V
    Perfusion; 2020 May; 35(1_suppl):29-33. PubMed ID: 32397880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vitro Evaluation of Pediatric Hollow-Fiber Membrane Oxygenators on Hemodynamic Performance and Gaseous Microemboli Handling: An International Multicenter/Multidisciplinary Approach.
    Wang S; Caneo LF; Jatene MB; Jatene FB; Cestari IA; Kunselman AR; Ündar A
    Artif Organs; 2017 Sep; 41(9):865-874. PubMed ID: 28597590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A wet-primed extracorporeal membrane oxygenation circuit with hollow-fiber membrane oxygenator maintains adequate function for use during cardiopulmonary resuscitation after 2 weeks on standby.
    Karimova A; Robertson A; Cross N; Smith L; O'callaghan M; Tuleu C; Long P; Beeton A; Han J; Ridout D; Goldman A; Brown K
    Crit Care Med; 2005 Jul; 33(7):1572-6. PubMed ID: 16003064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced hemolysis in pediatric patients requiring extracorporeal membrane oxygenation and continuous renal replacement therapy.
    Betrus C; Remenapp R; Charpie J; Kudelka T; Brophy P; Smoyer WE; Lin JJ
    Ann Thorac Cardiovasc Surg; 2007 Dec; 13(6):378-83. PubMed ID: 18292719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effect of membrane sizes and fibre arrangements of two membrane oxygenators on the inflammatory response, oxygenation and decarboxylation in a rat model of extracorporeal membrane oxygenation.
    Edinger F; Schneck E; Schulte C; Gehron J; Mueller S; Sander M; Koch C
    BMC Cardiovasc Disord; 2020 Jun; 20(1):294. PubMed ID: 32539686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database for Patient- and Circuit-Related Adverse Events Involving Extracorporeal Membrane Oxygenation.
    Khalid N; Javed H; Ahmad SA; Edelman JJ; Shlofmitz E; Chen Y; Musallam A; Rogers T; Hashim H; Bernardo NL; Waksman R
    Cardiovasc Revasc Med; 2020 Feb; 21(2):230-234. PubMed ID: 31767523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro effects of an extracorporeal membrane oxygenation circuit on the sequestration of ϵ-aminocaproic acid.
    Wagner D; Caraballo M; Waldvogel J; Peterson Y; Sun D
    Perfusion; 2017 Apr; 32(3):226-229. PubMed ID: 27815558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Capiox RX25 and Quadrox-i Adult Hollow Fiber Membrane Oxygenators in a Simulated Cardiopulmonary Bypass Circuit.
    Wang S; Kunselman AR; Ündar A
    Artif Organs; 2016 May; 40(5):E69-78. PubMed ID: 27168381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Combined Extracorporeal Life Support and Continuous Renal Replacement Therapy on Hemodynamic Performance and Gaseous Microemboli Handling Ability in a Simulated Neonatal ECLS System.
    Shank KR; Profeta E; Wang S; O'Connor C; Kunselman AR; Woitas K; Myers JL; Ündar A
    Artif Organs; 2018 Apr; 42(4):365-376. PubMed ID: 28940550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Normobaric versus Hypobaric Oxygenation on Gaseous Microemboli Removal in a Diffusion Membrane Oxygenator: An In Vitro Comparison.
    Schuldes M; Riley JB; Francis SG; Clingan S
    J Extra Corpor Technol; 2016 Sep; 48(3):129-136. PubMed ID: 27729706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Pulsatile Control Algorithms for Diagonal Pump on Hemodynamic Performance and Hemolysis.
    Wang S; Force M; Moroi MK; Patel S; Kunselman AR; Ündar A
    Artif Organs; 2019 Jan; 43(1):60-75. PubMed ID: 30374991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A description of a prototype miniature extracorporeal membrane oxygenation circuit using current technologies in a sheep model.
    Terry B; Gunst G; Melchior R; Wolfe D; Feocco N; Graham S; Searles B; Darling E
    J Extra Corpor Technol; 2005 Sep; 37(3):315-7. PubMed ID: 16350388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving ECMO therapy: Monitoring oxygenator functionality and identifying key indicators, factors, and considerations for changeout.
    Butt SP; Razzaq N; Saleem Y; Cook B; Abdulaziz S
    J Extra Corpor Technol; 2024 Mar; 56(1):20-29. PubMed ID: 38488715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-derived microparticles generated by neonatal extracorporeal membrane oxygenation systems.
    Meyer AD; Gelfond JA; Wiles AA; Freishtat RJ; Rais-Bahrami K
    ASAIO J; 2015; 61(1):37-42. PubMed ID: 25303795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.